ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma

This study is currently recruiting participants.
Study NCT00684411.   Last updated on June 16, 2008.   Information provided by Dana-Farber Cancer Institute
Please refer to this study by its ClinicalTrials.gov identifier: NCT00684411


Contacts
Contact: Eric Jacobsen, MD     617-632-6633     Eric_Jacobsen@dfci.harvard.edu    
Contact: Hazel Reynolds     617-632-6840    

Locations
United States, Massachusetts
Dana-Farber Cancer Institute     Recruiting
      Boston, Massachusetts, United States, 02115

Sponsors and Collaborators
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Novartis

Investigators
Principal Investigator:     Eric Jacobsen, MD     Dana-Farber Cancer Institute    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers